Alcon switches Pataday eye allergy drops in US

19 February 2020 - Deborah Wilkes

Premium

Alcon is launching two OTC versions of its Pataday (olopatadine hydrochloride) eye allergy drops in the US after the US Food and Drug Administration (FDA) approved a switch from prescription-to-OTC status for the medicines.

Click tags below for more information on topics:

Alcon

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: